1. Therapeutic Potential of Dental Pulp Stem Cells and Leukocyte- and Platelet-Rich Fibrin for Osteoarthritis.
- Author
-
Lo Monaco M, Gervois P, Beaumont J, Clegg P, Bronckaers A, Vandeweerd JM, and Lambrichts I
- Subjects
- Adolescent, Animals, Cell Differentiation drug effects, Cell Proliferation drug effects, Cell Survival drug effects, Chondrocytes drug effects, Chondrocytes ultrastructure, Chondrogenesis drug effects, Culture Media, Conditioned pharmacology, Dinoprostone metabolism, Extracellular Matrix drug effects, Extracellular Matrix metabolism, Female, Humans, Interleukin-1beta pharmacology, Interleukin-6 metabolism, Male, Mesenchymal Stem Cells cytology, Mesenchymal Stem Cells drug effects, Mice, Inbred C57BL, Nitrites metabolism, Osteoarthritis pathology, Phenotype, RNA, Messenger genetics, RNA, Messenger metabolism, Stem Cells drug effects, Tumor Necrosis Factor-alpha pharmacology, Young Adult, Dental Pulp cytology, Leukocytes metabolism, Osteoarthritis therapy, Platelet-Rich Fibrin metabolism, Stem Cell Transplantation, Stem Cells cytology
- Abstract
Osteoarthritis (OA) is a degenerative and inflammatory joint disorder with cartilage loss. Dental pulp stem cells (DPSCs) can undergo chondrogenic differentiation and secrete growth factors associated with tissue repair and immunomodulation. Leukocyte- and platelet-rich fibrin (L-PRF) emerges in regenerative medicine because of its growth factor content and fibrin matrix. This study evaluates the therapeutic application of DPSCs and L-PRF in OA via immunomodulation and cartilage regeneration. Chondrogenic differentiation of DPSCs, with or without L-PRF exudate (ex) and conditioned medium (CM), and of bone marrow-mesenchymal stem cells was compared. These cells showed differential chondrogenesis. L-PRF was unable to increase cartilage-associated components. Immature murine articular chondrocytes (iMACs) were cultured with L-PRF ex, L-PRF CM, or DPSC CM. L-PRF CM had pro-survival and proliferative effects on unstimulated and cytokine-stimulated iMACs. L-PRF CM stimulated the release of IL-6 and PGE2, and increased MMP-13 , TIMP-1 and IL-6 mRNA levels in cytokine-stimulated iMACs. DPSC CM increased the survival and proliferation of unstimulated iMACs. In cytokine-stimulated iMACs, DPSC CM increased TIMP-1 gene expression, whereas it inhibited nitrite release in 3D culture. We showed promising effects of DPSCs in an in vitro OA model, as they undergo chondrogenesis in vitro, stimulate the survival of chondrocytes and have immunomodulatory effects.
- Published
- 2020
- Full Text
- View/download PDF